Azenta, Inc. (AZTA)
| Market Cap | 3.63B |
| Revenue (ttm) | 665.07M |
| Net Income (ttm) | -14.26M |
| Shares Out | 55.72M |
| EPS (ttm) | -0.22 |
| PE Ratio | n/a |
| Forward PE | 254.23 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 275,867 |
| Open | 65.98 |
| Previous Close | 66.26 |
| Day's Range | 65.03 - 66.49 |
| 52-Week Range | 36.01 - 66.98 |
| Beta | 1.57 |
| Analysts | Buy |
| Price Target | 63.25 (-2.9%) |
| Earnings Date | Feb 7, 2024 |
About AZTA
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segmen... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 6 analysts, the average rating for AZTA stock is "Buy." The 12-month stock price forecast is $63.25, which is a decrease of -2.90% from the latest price.
News
Final Trade: DISH, GLD, EWJ and AZTA
The final trades of the day with the 'Fast Money' traders.
Azenta to Participate in the 6th Annual Evercore ISI HealthCONx Conference
BURLINGTON, Mass. , Nov. 21, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in 1x1 meetings at the 6th Annual Evercore ISI HealthCONx Confere...
Azenta shares jump on Q4 results, buyback plans
Shares of Azenta Inc. AZTA, +0.59% jumped 11.9% after hours on Monday after the life-sciences company reported fourth-quarter results that beat expectations and announced plans to buy back an extra $5...
Azenta Reports Fourth Quarter and Full Year Fiscal 2023 Results, Ended September 30, 2023
Q4'23 reported revenue growth of 25% year over year and 2% on an organic basis FY'23 reported revenue growth of 20% and down 1% on an organic basis Q4'23 generated positive free cash flow for the seco...
Azenta Announces Actions to Support Ongoing Strategic and Governance Transformation
Nominates Didier Hirsch and Martin Madaus for election to the Board of Directors Upon the election of Messrs. Hirsch and Madaus, seven of the Board of Directors' ten members will have been added since...
Azenta Announces Agreement Between B Medical and The Ministry of Public Health, Hygiene and Prevention of the Democratic Republic of the Congo for a Significant National Universal Health Project
BURLINGTON, Mass. , Nov. 13, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that B Medical Systems S.
Azenta to Participate in the Stephens Annual Investment Conference
BURLINGTON, Mass., Nov. 10, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Stephens Annual Investment Conference in Nashville, Tenness...
Azenta Announces Fiscal 2023 Fourth Quarter and Full Year Earnings Conference Call and Webcast
BURLINGTON, Mass. , Nov. 8, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2023 earnings which ended on September 30, 2023 on Monday, November 13, 2...
Azenta to Host GENEWIZ Week November 6-10, 2023
BURLINGTON, Mass. , Oct. 19, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting GENEWIZ Week Nov...
Activist Politan Capital engages with Azenta. Here's how the firm may boost shareholder value
Azenta is sitting on a pile of cash, and shareholders will want to know the company's plans for the money.
Azenta Announces CFO Transition
Industry Veteran Herman Cueto Named CFO Azenta CFO Lindon Robertson to Retire Company Reaffirms Guidance for Fourth Quarter Fiscal 2023 BURLINGTON, Mass. , Sept. 26, 2023 /PRNewswire/ -- Azenta, Inc. ...
Azenta to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
BURLINGTON, Mass. , Sept. 8, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Morgan Stanley 21st Annual Global Healthcare Conference in...
Azenta to Participate in the Baird 2023 Global Healthcare Conference
BURLINGTON, Mass. , Sept. 7, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Baird 2023 Global Healthcare Conference in New York, NY, o...
Azenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023
BURLINGTON, Mass. , Aug. 10, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS MedTech, Tools and Genomics Summit 2023 in Dana Point,...
Azenta to Participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1X1 Conference
BURLINGTON, Mass. , Aug. 9, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1x1 Confer...
Azenta Reports Results of Third Quarter of Fiscal 2023, Ended June 30, 2023
BURLINGTON, Mass. , Aug. 8, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2023.
Azenta Announces Fiscal 2023 Third Quarter Earnings Conference Call and Webcast
BURLINGTON, Mass. , Aug. 3, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2023 earnings which ended on June 30, 2023 on Tuesday August 8, 2023 after the market cl...
Azenta Announces New Biorepository in the Greater Boston Area
Azenta has selected the greater Boston area, a key pharma and biotech hub, as the next location to expand its global biorepository footprint. BURLINGTON, Mass.
Vazyme Signs Global Strategic Cooperation Agreement with Azenta
NANJING, China , May 31, 2023 /PRNewswire/ -- Vazyme (688105.SH), China's leading biotechnology company, has officially signed a global strategic cooperation agreement with Azenta Life Sciences ("Azen...
Azenta to Participate in the Jefferies Healthcare Conference
BURLINGTON, Mass. , May 30, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Jefferies Healthcare Conference in New York, NY, on Thursda...
Azenta Announces Collaboration with the Lupus Research Alliance to Support the Advancement of Lupus Research and Drug Discovery
Azenta has been Selected by the Lupus Research Alliance as its Sample Management Services Provider and Partner in Supporting the Development of the Patient Registry Component of the Lupus Nexus BURLIN...
Azenta to Participate in the 23rd Annual B. Riley Securities Institutional Investor Conference
BURLINGTON, Mass. , May 17, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 23rd Annual B.
Azenta Reports Results of Second Quarter of Fiscal 2023 and Announces Business Realignment
BURLINGTON, Mass. , May 9, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2023.
Azenta Announces Fiscal 2023 Second Quarter Earnings Conference Call and Webcast
BURLINGTON, Mass. , May 3, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2023 earnings which ended on March 31, 2023 on Tuesday, May 9, 2023 after the market clo...
Azenta to Participate in the 22nd Annual Needham Virtual Healthcare Conference
BURLINGTON, Mass. , April 13, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 22nd Annual Needham Virtual Healthcare Conference on Tues...